{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "The Bonus Track Survives; PMA Preemption Cuts the Rest",
    "url": "https://www.lexblog.com/2026/10/13/the-bonus-track-survives-pma-preemption-cuts-the-rest/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-V1JRVMKM",
        "url": "https://www.lexblog.com/lib/V1JRVMKM/"
    },
    "datePublished": "2026-10-13T06:04:00-04:00",
    "dateModified": "2026-10-13T06:04:00-04:00",
    "author": {
        "@type": "Person",
        "name": "Michelle Yeary"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Drug & Device Law Blogging Team"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Drug & Device Law",
    "about": "Health Care and Life Sciences · Personal Injury",
    "sourceUrl": "https://www.druganddevicelawblog.com/?p=47213",
    "sourceStability": "may-move"
}